HomeCompareRAIO vs JNJ

RAIO vs JNJ: Dividend Comparison 2026

RAIO yields 1538461.54% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RAIO wins by $3.540085451380792e+38M in total portfolio value
10 years
RAIO
RAIO
● Live price
1538461.54%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.540085451380792e+38M
Annual income
$353,963,285,679,818,570,000,000,000,000,000,000,000,000,000.00
Full RAIO calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — RAIO vs JNJ

📍 RAIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRAIOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RAIO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RAIO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RAIO
Annual income on $10K today (after 15% tax)
$130,769,230.77/yr
After 10yr DRIP, annual income (after tax)
$300,868,792,827,845,760,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, RAIO beats the other by $300,868,792,827,845,760,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RAIO + JNJ for your $10,000?

RAIO: 50%JNJ: 50%
100% JNJ50/50100% RAIO
Portfolio after 10yr
$1.770042725690396e+38M
Annual income
$176,981,642,839,909,280,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RAIO
No analyst data
Altman Z
-232.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RAIO buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRAIOJNJ
Forward yield1538461.54%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$3.540085451380792e+38M$30.3K
Annual income after 10y$353,963,285,679,818,570,000,000,000,000,000,000,000,000,000.00$4,689.40
Total dividends collected$3.540055839082662e+38M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RAIO vs JNJ ($10,000, DRIP)

YearRAIO PortfolioRAIO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$153,856,854$153,846,153.85$10,592$272.30+$153.85MRAIO
2$2,212,340,814,413$2,212,176,187,579.49$11,289$357.73+$2212340.80MRAIO
3$29,730,738,703,870,012$29,728,371,499,198,588.00$12,123$472.89+$29730738703.86MRAIO
4$373,403,179,311,424,900,000$373,371,367,421,011,800,000.00$13,141$629.86+$373403179311424.94MRAIO
5$4,382,976,428,478,933,400,000,000$4,382,576,887,077,070,000,000,000.00$14,408$846.81+$4382976428478933504.00MRAIO
6$48,081,637,761,827,215,000,000,000,000$48,076,947,977,048,740,000,000,000,000.00$16,021$1,151.60+$4.808163776182721e+22MRAIO
7$492,956,453,982,496,560,000,000,000,000,000$492,905,006,630,091,400,000,000,000,000,000.00$18,122$1,588.22+$4.929564539824966e+26MRAIO
8$4,723,427,532,297,191,500,000,000,000,000,000,000$4,722,900,068,891,430,000,000,000,000,000,000,000.00$20,930$2,228.20+$4.723427532297192e+30MRAIO
9$42,298,559,122,077,037,000,000,000,000,000,000,000,000$42,293,505,054,617,480,000,000,000,000,000,000,000,000.00$24,792$3,191.91+$4.229855912207703e+34MRAIO
10$354,008,545,138,079,200,000,000,000,000,000,000,000,000,000$353,963,285,679,818,570,000,000,000,000,000,000,000,000,000.00$30,274$4,689.40+$3.540085451380792e+38MRAIO

RAIO vs JNJ: Complete Analysis 2026

RAIOStock

Radioio, Inc. operates an Internet media platform that provides streamed music to targeted audiences. Radioio broadcasts 140 streaming channels, and offers Internet radio services, including customized channels with various genres of music ranging from high-brow classical to acid rock. The company also provides a background music and messaging ecosystem for large franchise businesses and other vertical markets, such as retail, hospitality, and health and wellness. In addition, it offers Radioio live channels that stream live and pre-recorded talk radio content over the Internet to individual customers via advertising. The company was formerly known as ioWorldMedia, Incorporated and changed its name to Radioio, Inc. December 2013. Radioio, Inc. was incorporated in 1995 and is based in New York, New York.

Full RAIO Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RAIO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RAIO vs SCHDRAIO vs JEPIRAIO vs ORAIO vs KORAIO vs MAINRAIO vs ABBVRAIO vs MRKRAIO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.